| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Sales | $4.9M+7.5% | $4.6M+11.2% | $4.1M+279.6% | $1.1M |
| Cost of sales | $3.2M-7.5% | $3.5M+28.0% | $2.7M+400.6% | $546K |
| Gross profit | $1.7M+55.0% | $1.1M-21.5% | $1.4M+158.1% | $544K |
| Research and development | $2.9M-11.3% | $3.2M-13.8% | $3.7M-48.8% | $7.3M |
| General and administrative | $6.6M+13.1% | $5.8M-0.8% | $5.8M-14.8% | $6.9M |
| Amortization and depreciation | $213K-3.1% | $220K+8.6% | $202K+8.9% | $186K |
| Foreign Exchange Loss | $28K-54.0% | $62K+28.5% | $48K | — |
| Total operating expenses | $9.7M+3.8% | $9.3M-5.4% | $9.8M-44.8% | $17.8M |
| Interest and other income | $156K-70.5% | $528K+7.2% | $492K+412.5% | $96K |
| Finance expense | -$372K | — | — | — |
| Loss before income tax expense | -$8.2M-6.4% | -$7.7M+3.4% | -$7.9M+57.3% | -$18.6M |
| Income tax expense | -$7K | — | -$13K | — |
| Net loss for the year | -$8.2M-6.3% | -$7.7M+3.4% | -$7.9M+57.3% | -$18.6M |
| Basic (in Dollars per share) | -$8.36+58.5% | -$20.14-519.7% | -$3.25+90.2% | -$33.17 |
| Diluted (in Dollars per share) | -$8.36+58.5% | -$20.14 | — | — |
| Basic (in Shares) | 976K+156.1% | 381K-84.4% | 2.4M+336.6% | 561K |
| Diluted (in Shares) | 976K+156.1% | 381K | — | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.